THE POTENTIAL USE OF A MODIFIED-LIVE FIPV VACCINE TO PREVENT EXPERIMENTAL FECV INFECTION

Authors
HOSKINS JD HENK WG STORZ J KEARNEY MT
Citation
Jd. Hoskins et al., THE POTENTIAL USE OF A MODIFIED-LIVE FIPV VACCINE TO PREVENT EXPERIMENTAL FECV INFECTION, Feline practice, 23(3), 1995, pp. 89-90
Citations number
NO
Categorie Soggetti
Veterinary Sciences
Journal title
Feline practice → ACNP
ISSN journal
10576614
Volume
23
Issue
3
Year of publication
1995
Pages
89 - 90
Database
ISI
SICI code
1057-6614(1995)23:3<89:TPUOAM>2.0.ZU;2-T
Abstract
A study was undertaken to test whether a live FIPV vaccine would prote ct 9-week-old feline coronavirus seronegative kittens from feline ente ric coronavirus (FECV)-induced enteric disease. The vaccine appeared t o be safe when administered to kittens of this age. Vaccinated kittens demonstrated protection to FECV challenge-exposure compared to nonimm unized animals as evidenced by milder disease signs and less virus she dding in their feces.